-
1
-
-
0033378823
-
Nephropathic nature of proteinuria
-
Remuzzi G. Nephropathic nature of proteinuria. Curr Opin Nephrol Hypertens 1999;8(6):655-63.
-
(1999)
Curr Opin Nephrol Hypertens
, vol.8
, Issue.6
, pp. 655-663
-
-
Remuzzi, G.1
-
2
-
-
0033620802
-
Renoprotective therapy: Titration against urinary protein excretion
-
De Jong PE, Navis G, de Zeeuw D. Renoprotective therapy: titration against urinary protein excretion. Lancet 1999;354(9176):352-3.
-
(1999)
Lancet
, vol.354
, Issue.9176
, pp. 352-353
-
-
De Jong, P.E.1
Navis, G.2
De Zeeuw, D.3
-
3
-
-
0027962664
-
ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects
-
Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetes Complications 1994; 8(1):2-6.
-
(1994)
J Diabetes Complications
, vol.8
, Issue.1
, pp. 2-6
-
-
Bakris, G.L.1
Slataper, R.2
Vicknair, N.3
Sadler, R.4
-
4
-
-
0028295765
-
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
-
Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 1994;45(3):861-7.
-
(1994)
Kidney Int
, vol.45
, Issue.3
, pp. 861-867
-
-
Gansevoort, R.T.1
De Zeeuw, D.2
De Jong, P.E.3
-
5
-
-
0033917552
-
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
-
Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int 2000;57(2):601-6.
-
(2000)
Kidney Int
, vol.57
, Issue.2
, pp. 601-606
-
-
Andersen, S.1
Tarnow, L.2
Rossing, P.3
Hansen, B.V.4
Parving, H.H.5
-
6
-
-
0034286103
-
Effectively targeting the- Renin-angiotensin system in cardiovascular and renal disease: Rationale for using angiotensin II receptor blockers in combination with angiotensin converting enzyme-inhibitors
-
Weinberg MS, Weinberg AJ, Zappe DH. Effectively targeting the-renin-angiotensin system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin converting enzyme-inhibitors. JRAAS 2000;1(3):217-33.
-
(2000)
JRAAS
, vol.1
, Issue.3
, pp. 217-233
-
-
Weinberg, M.S.1
Weinberg, A.J.2
Zappe, D.H.3
-
7
-
-
0031688757
-
Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system
-
Hollenberg NK, Fisher NDL, Price DA. Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system. Hypertension 1998;32:387-92.
-
(1998)
Hypertension
, vol.32
, pp. 387-392
-
-
Hollenberg, N.K.1
Fisher, N.D.L.2
Price, D.A.3
-
8
-
-
0025073099
-
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition
-
Mooser V, Nussberger J, Juillerat I. et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990;15(2): 276-82.
-
(1990)
J Cardiovasc Pharmacol
, vol.15
, Issue.2
, pp. 276-282
-
-
Mooser, V.1
Nussberger, J.2
Juillerat, I.3
-
9
-
-
0032439783
-
Impact of salt intake on blood pressure and proteinuria in diabetes: Importance of the renin-angiotensin system
-
Weir MR. Impact of salt intake on blood pressure and proteinuria in diabetes: importance of the renin-angiotensin system. Miner Electrolyte Metab 1998;24(6):438-45.
-
(1998)
Miner Electrolyte Metab
, vol.24
, Issue.6
, pp. 438-445
-
-
Weir, M.R.1
-
10
-
-
0033237251
-
Dosing angiotensin II blockers - Beyond blood pressure
-
Peters H, Ritz E. Dosing angiotensin II blockers - beyond blood pressure. Nephrol Dial Transplant 1999;14:2568-70.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 2568-2570
-
-
Peters, H.1
Ritz, E.2
|
